Christoph Wanner
University of Toronto
Affiliation University of Toronto Top Publications Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes (2015) – 12,327 citations 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice (2021) – 6,608 citations Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure (2020) – 5,245 citations Empagliflozin and Progression of Kidney Disease in Type 2 ... <a title="Christoph Wanner" class="read-more" href="https://journalsworld.com/researchers/christoph-wanner/" aria-label="Read more about Christoph Wanner">Read more</a>
Read biography ↓Biography, research & contributions
Affiliation
University of Toronto
Top Publications
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes (2015) - 12,327 citations
- 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice (2021) - 6,608 citations
- Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure (2020) - 5,245 citations
- Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes (2016) - 3,689 citations
- 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension (2023) - 3,433 citations
At a glance
- Full name
- Christoph Wanner
- ORCID
- 0000-0001-9507-5301
- OpenAlex ID
- https://openalex.org/A5033368647
Research interests
- Chronic Kidney Disease and Diabetes, Dialysis and Renal Disease Management, Diabetes Treatment and Management, Acute Kidney Injury Research, Lysosomal Storage Disorders Research
Research topics
Education
Not yet documented in this profile.
Selected research & further reading
A curated reading list, not a ranking by citation count. References use DOI metadata, matching public scholarly records or authoritative lecture sources.
See the source-linked reading and original works in the research guide above.
Citation & publication trends
Annual counts are not yet available from a verified author record. Explore the research guide above for the work itself; publication and citation totals depend on database coverage.
Source: OpenAlex · Retrieved 2026-10-07. Metrics are database-specific and are not a scientific ranking.
Most-cited linked publications
Publications matched across ORCID and OpenAlex. Citation counts are source-specific.
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes ↗2015 · New England Journal of Medicine12,327OpenAlex citations
- 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice ↗2021 · European Heart Journal6,608OpenAlex citations
- Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure ↗2020 · New England Journal of Medicine5,245OpenAlex citations
- Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes ↗2016 · New England Journal of Medicine3,689OpenAlex citations
- 3,433OpenAlex citations
Recent linked publications
Publications matched across ORCID and OpenAlex. Citation counts are source-specific.
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes ↗2015 · New England Journal of Medicine
- 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice ↗2021 · European Heart Journal
- Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure ↗2020 · New England Journal of Medicine
- Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes ↗2016 · New England Journal of Medicine
Journals published in
No verified record links added yet.
Related publishers
No verified record links added yet.
Institutions
Current verified institution
No verified record links added yet.
Previous institutions
No verified record links added yet.
Awards & honors
Not yet documented in this profile.
Career timeline
Not yet documented in this profile.
Co-authors
No verified record links added yet.
Education & career institution links
No verified record links added yet.
Claim & manage this profile
Are you this researcher? Sign in, provide identity evidence, and request administrator approval. Editing becomes available only after approval.
Sign in to claim this profileSources & data information
Editorial review: 2026-10-07 · Last data update: 2026-10-07 20:37:38
Unknown values are left blank. Linked publications may be a subset of total works. Identity verification, data retrieval and profile ownership are separate checks.